FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2022
Back to search
Official data from USPTO
SELF RX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/29/2022
Trademark type
Combined
Nice classes
5
Filing date
11/05/2020
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
LAVACHE, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "SELF RX" in purple, where the top portion of the letter "R" forms a mortar in which an orange pestle appears to sit.
Holders and representatives
Holders
Dong-A Pharmaceutical Co., Ltd.
Representatives
GREGG A. PARADISE LERNER, DAVID, LITTENBERG, ET AL.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Health food supplements based mainly on eggs; protein dietary supplements; nutritional supplements consisting primarily of magnesium; food supplements consisting of minerals; mineral nutritional supplements; dietary supplements consisting of vitaminsmineralsamino acids and trace elements; vitamin preparations; nutraceuticals for use as a dietary supplement; dietary supplement drinks; nutraceuticals for use as dietary supplements; dietary and nutritional supplements; vitamin preparations in the nature of food supplements; nutritional supplements; pharmaceuticals for supporting liver healthprostate healthskin healthjoint healthbones and teeth healtheye health and promoting digestion and improving blood flow and boosting immunity; nutraceuticals for therapeutic purposes for supporting liver healthprostate healthskin healthjoint healthbones and teeth healtheye health and promoting digestion and improving blood flow and boosting immunity; nutraceutical preparations for therapeutic or medical purposes for supporting liver healthprostate healthskin healthjoint healthbones and teeth healtheye health and promoting digestion and improving blood flow and boosting immunity; calcium supplements
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/06/2022
FIMP
FINAL DISPOSITION PROCESSED
08/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/21/2021
PUBO
PUBLISHED FOR OPPOSITION
12/21/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/01/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/16/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/16/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/16/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/16/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/29/2021
GNFR
FINAL REFUSAL E-MAILED
07/29/2021
CNFR
FINAL REFUSAL WRITTEN
07/29/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2021
RFNT
REFUSAL PROCESSED BY IB
05/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/21/2021
RFRR
REFUSAL PROCESSED BY MPU
04/21/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/20/2021
CNRT
NON-FINAL ACTION WRITTEN
04/19/2021
DOCK
ASSIGNED TO EXAMINER
04/13/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/07/2021
Continuous trademark protection
Get notified about every new filing that threatens SELF RX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.